Showing results (31-40 of 403) with videos related to
Sort By:
Pageof 41
The Journal of Antimicrobial Chemotherapy|June 25, 1999
Liposomal nystatin against experimental pulmonary aspergillosis in persistently neutropenic rabbits: efficacy, safety and non-compartmental pharmacokineticsA H Groll, C E Gonzalez, N Giri, et al.Antimicrobial Agents and Chemotherapy|October 31, 1998
Antifungal efficacy, safety, and single-dose pharmacokinetics of LY303366, a novel echinocandin B, in experimental pulmonary aspergillosis in persistently neutropenic rabbitsV Petraitis, R Petraitiene, A H Groll, et al.Antimicrobial Agents and Chemotherapy|February 13, 2001
Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasisV Petraitis, R Petraitiene, A H Groll, et al.Klinische Padiatrie|September 29, 2001
[Guidelines for Prevention of Pneumocystis carinii Pneumonitis in Children and Adolescents with Cancer]A H Groll, J Ritter, F M MüllerCurrent Opinion in Pediatrics|March 20, 1999
Treatment of fungal infections in neutropenic childrenT Lehrnbecher, A H Groll, S J ChanockKlinische Padiatrie|September 29, 2001
[Prevention of fungal infections in children and adolescents with cancer]A H Groll, J Ritter, F M MüllerCritical Care Clinics|April 1, 1988
The febrile granulocytopenic patient in the intensive care unitT J WalshHematology/Oncology Clinics of North America|October 1, 1993
Management of immunocompromised patients with evidence of an invasive mycosisT J WalshNCI Monographs : a Publication of the National Cancer Institute|January 1, 1990
Role of surveillance cultures in prevention and treatment of fungal infectionsT J WalshSeminars in Respiratory Infections|June 1, 1990
Invasive pulmonary aspergillosis in patients with neoplastic diseasesT J WalshPageof 41